Clinical Trial Update: A Study for Tyrosine Kinase Inhibitors Discontinuation

View source ↗

Summary

This clinical trial update discusses a study examining discontinuation of tyrosine kinase inhibitors for patients with leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Snippet

Sponsor: Versailles Hospital | Conditions: Leukemia | Status: UNKNOWN